Epigenetic regulation of maspin expression in human ovarian carcinoma cells

Stephen L. Rose, Matthew P. Fitzgerald, Natalie O. White, Michael J. Hitchler, Bernard W. Futscher, Koenraad De Geest, Frederick E. Domann

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Objective.: Maspin expression is often deregulated in human cancer cells compared to their normal cells due to loss of epigenetic control. In contrast to normal human ovarian surface epithelial (HOSE) cells, ovarian carcinoma cells display a gain of maspin mRNA expression. The objective of this study was to determine whether gain of maspin expression in ovarian cancer is governed by epigenetic mechanisms. Methods.: We examined the cytosine methylation and chromatin accessibility status of the maspin promoter in normal HOSE cells and ovarian carcinoma cells with real-time RT-PCR, sodium bisulfite genomic sequencing, and chromatin accessibility assays. 5-Aza-2′-deoxycytidine (5-aza-dC) was used to induce demethylation of the maspin promoter. Ad p53 was used to induce transient overexpression of wild-type p53. Results.: Normal HOSE cells were maspin-negative in association with methylation of the maspin promoter. In the maspin-positive ovarian cancer cell lines, the maspin promoter was unmethylated. Increased maspin expression in ovarian carcinoma cells was accompanied by a more accessible chromatin structure in the maspin promoter. In the maspin-negative ovarian cancer cell line A222, maspin could be induced following 5-aza-dC treatment or by forced overexpression of p53. Conclusions.: These results suggest that changes in cytosine methylation and chromatin accessibility play an important role in maspin expression in human ovarian carcinoma. Deregulation of maspin expression in ovarian cancer is due to loss of epigenetic control as has been shown in other cancers. This observation provides further evidence of the strict epigenetic control of the maspin gene.

Original languageEnglish (US)
Pages (from-to)319-324
Number of pages6
JournalGynecologic Oncology
Volume102
Issue number2
DOIs
StatePublished - Aug 2006
Externally publishedYes

Fingerprint

Epigenomics
Carcinoma
decitabine
Ovarian Neoplasms
Chromatin
Methylation
SERPIN-B5
Epithelial Cells
Cytosine
Cell Line
Real-Time Polymerase Chain Reaction
Neoplasms

Keywords

  • Cancer
  • Chromatin
  • Methylation
  • Serpin

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Rose, S. L., Fitzgerald, M. P., White, N. O., Hitchler, M. J., Futscher, B. W., De Geest, K., & Domann, F. E. (2006). Epigenetic regulation of maspin expression in human ovarian carcinoma cells. Gynecologic Oncology, 102(2), 319-324. https://doi.org/10.1016/j.ygyno.2005.12.025

Epigenetic regulation of maspin expression in human ovarian carcinoma cells. / Rose, Stephen L.; Fitzgerald, Matthew P.; White, Natalie O.; Hitchler, Michael J.; Futscher, Bernard W.; De Geest, Koenraad; Domann, Frederick E.

In: Gynecologic Oncology, Vol. 102, No. 2, 08.2006, p. 319-324.

Research output: Contribution to journalArticle

Rose, SL, Fitzgerald, MP, White, NO, Hitchler, MJ, Futscher, BW, De Geest, K & Domann, FE 2006, 'Epigenetic regulation of maspin expression in human ovarian carcinoma cells', Gynecologic Oncology, vol. 102, no. 2, pp. 319-324. https://doi.org/10.1016/j.ygyno.2005.12.025
Rose, Stephen L. ; Fitzgerald, Matthew P. ; White, Natalie O. ; Hitchler, Michael J. ; Futscher, Bernard W. ; De Geest, Koenraad ; Domann, Frederick E. / Epigenetic regulation of maspin expression in human ovarian carcinoma cells. In: Gynecologic Oncology. 2006 ; Vol. 102, No. 2. pp. 319-324.
@article{3fe2a08a2f694273a20dc91e494a66f1,
title = "Epigenetic regulation of maspin expression in human ovarian carcinoma cells",
abstract = "Objective.: Maspin expression is often deregulated in human cancer cells compared to their normal cells due to loss of epigenetic control. In contrast to normal human ovarian surface epithelial (HOSE) cells, ovarian carcinoma cells display a gain of maspin mRNA expression. The objective of this study was to determine whether gain of maspin expression in ovarian cancer is governed by epigenetic mechanisms. Methods.: We examined the cytosine methylation and chromatin accessibility status of the maspin promoter in normal HOSE cells and ovarian carcinoma cells with real-time RT-PCR, sodium bisulfite genomic sequencing, and chromatin accessibility assays. 5-Aza-2′-deoxycytidine (5-aza-dC) was used to induce demethylation of the maspin promoter. Ad p53 was used to induce transient overexpression of wild-type p53. Results.: Normal HOSE cells were maspin-negative in association with methylation of the maspin promoter. In the maspin-positive ovarian cancer cell lines, the maspin promoter was unmethylated. Increased maspin expression in ovarian carcinoma cells was accompanied by a more accessible chromatin structure in the maspin promoter. In the maspin-negative ovarian cancer cell line A222, maspin could be induced following 5-aza-dC treatment or by forced overexpression of p53. Conclusions.: These results suggest that changes in cytosine methylation and chromatin accessibility play an important role in maspin expression in human ovarian carcinoma. Deregulation of maspin expression in ovarian cancer is due to loss of epigenetic control as has been shown in other cancers. This observation provides further evidence of the strict epigenetic control of the maspin gene.",
keywords = "Cancer, Chromatin, Methylation, Serpin",
author = "Rose, {Stephen L.} and Fitzgerald, {Matthew P.} and White, {Natalie O.} and Hitchler, {Michael J.} and Futscher, {Bernard W.} and {De Geest}, Koenraad and Domann, {Frederick E.}",
year = "2006",
month = "8",
doi = "10.1016/j.ygyno.2005.12.025",
language = "English (US)",
volume = "102",
pages = "319--324",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Epigenetic regulation of maspin expression in human ovarian carcinoma cells

AU - Rose, Stephen L.

AU - Fitzgerald, Matthew P.

AU - White, Natalie O.

AU - Hitchler, Michael J.

AU - Futscher, Bernard W.

AU - De Geest, Koenraad

AU - Domann, Frederick E.

PY - 2006/8

Y1 - 2006/8

N2 - Objective.: Maspin expression is often deregulated in human cancer cells compared to their normal cells due to loss of epigenetic control. In contrast to normal human ovarian surface epithelial (HOSE) cells, ovarian carcinoma cells display a gain of maspin mRNA expression. The objective of this study was to determine whether gain of maspin expression in ovarian cancer is governed by epigenetic mechanisms. Methods.: We examined the cytosine methylation and chromatin accessibility status of the maspin promoter in normal HOSE cells and ovarian carcinoma cells with real-time RT-PCR, sodium bisulfite genomic sequencing, and chromatin accessibility assays. 5-Aza-2′-deoxycytidine (5-aza-dC) was used to induce demethylation of the maspin promoter. Ad p53 was used to induce transient overexpression of wild-type p53. Results.: Normal HOSE cells were maspin-negative in association with methylation of the maspin promoter. In the maspin-positive ovarian cancer cell lines, the maspin promoter was unmethylated. Increased maspin expression in ovarian carcinoma cells was accompanied by a more accessible chromatin structure in the maspin promoter. In the maspin-negative ovarian cancer cell line A222, maspin could be induced following 5-aza-dC treatment or by forced overexpression of p53. Conclusions.: These results suggest that changes in cytosine methylation and chromatin accessibility play an important role in maspin expression in human ovarian carcinoma. Deregulation of maspin expression in ovarian cancer is due to loss of epigenetic control as has been shown in other cancers. This observation provides further evidence of the strict epigenetic control of the maspin gene.

AB - Objective.: Maspin expression is often deregulated in human cancer cells compared to their normal cells due to loss of epigenetic control. In contrast to normal human ovarian surface epithelial (HOSE) cells, ovarian carcinoma cells display a gain of maspin mRNA expression. The objective of this study was to determine whether gain of maspin expression in ovarian cancer is governed by epigenetic mechanisms. Methods.: We examined the cytosine methylation and chromatin accessibility status of the maspin promoter in normal HOSE cells and ovarian carcinoma cells with real-time RT-PCR, sodium bisulfite genomic sequencing, and chromatin accessibility assays. 5-Aza-2′-deoxycytidine (5-aza-dC) was used to induce demethylation of the maspin promoter. Ad p53 was used to induce transient overexpression of wild-type p53. Results.: Normal HOSE cells were maspin-negative in association with methylation of the maspin promoter. In the maspin-positive ovarian cancer cell lines, the maspin promoter was unmethylated. Increased maspin expression in ovarian carcinoma cells was accompanied by a more accessible chromatin structure in the maspin promoter. In the maspin-negative ovarian cancer cell line A222, maspin could be induced following 5-aza-dC treatment or by forced overexpression of p53. Conclusions.: These results suggest that changes in cytosine methylation and chromatin accessibility play an important role in maspin expression in human ovarian carcinoma. Deregulation of maspin expression in ovarian cancer is due to loss of epigenetic control as has been shown in other cancers. This observation provides further evidence of the strict epigenetic control of the maspin gene.

KW - Cancer

KW - Chromatin

KW - Methylation

KW - Serpin

UR - http://www.scopus.com/inward/record.url?scp=33745964874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745964874&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2005.12.025

DO - 10.1016/j.ygyno.2005.12.025

M3 - Article

C2 - 16457875

AN - SCOPUS:33745964874

VL - 102

SP - 319

EP - 324

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -